Clinical Trial Sites

We are currently engaged in or have completed clinical trials in cooperation with the following medical centers:

Spinal Cord Injury

Balgrist University Hospital, University of Zurich
StemCells is conducting a Phase I/II clinical trial of HuCNS-SC cells in Switzerland at the Balgrist University Hospital, University of Zurich, one of the leading medical centers in the world for spinal cord injury and rehabilitation.   The principal investigator is Armin Curt, MD, Professor and Chairman, Spinal Cord Injury Center at the University of Zurich, and Medical Director of the Paraplegic Center at the Balgrist University Hospital.   Dr. Curt is an internationally renowned medical expert in spinal cord injury.  The trial was initiated in March 2011, and is currently open for enrollment.

PMD

UCSF Children’s Hospital
StemCells is conducting a Phase I clinical trial of HuCNS-SC cells in PMD at the University of California, San Francisco (UCSF) Children’s Hospital in collaboration with Principal Investigator David H. Rowitch, MD, PhD, chief of Neonatology, professor of Pediatrics and Neurological Surgery, member of the Eli and Edythe Broad Center of Regeneration Medicine and Stem Cell Research, and a Howard Hughes Medical Institute investigator; and Co-investigators Nalin Gupta, MD, PhD, chief of Pediatric Neurological Surgery and Jonathan B. Strober, MD, director of Clinical Services for Child Neurology and director of the Muscular Dystrophy Clinic.

NCL

OHSU Doernbecher Children’s Hospital

StemCells has completed a Phase I clinical trial of HuCNS-SC cells in NCL at Oregon Health & Science University (OHSU) Doernbecher Children’s Hospital in collaboration with Principal Investigators Robert Steiner, M.D., FAAP, FACMG, professor of Pediatrics and Molecular and Medical Genetics, and vice chairman for Pediatric Research, and Nathan Selden, M.D., Ph.D., FACS, FAAP, Campagna Professor of Pediatric Neurosurgery and head of the Division of Pediatric Neurological Surgery at OHSU Doernbecher Children’s Hospital and OHSU School of Medicine.

Patient Enrollment

Spinal Cord Injury Trial –

For enrollment inquiries, please contact the trial site
in Switzerland at
+41 44 386 59 70 or at stemcells.pz@balgrist.ch.

PMD Trial –

Enrollment in our Phase I PMD Trial is now complete. Visit the UCSF website to learn more about the trial …

Please Note!

You are about to open a web page or document that is hosted by a third party and is not maintained by StemCells, Inc. and to which our Privacy Policy does not apply.

This link is provided to you for convenience and does not serve as an endorsement by StemCells, Inc. of any information or contacts that you may find on this third party site.

Cancel | Continue

X